Maridea Wealth Management LLC Boosts Stake in HealthEquity, Inc. $HQY

Maridea Wealth Management LLC increased its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 40.1% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 29,272 shares of the company’s stock after acquiring an additional 8,379 shares during the period. Maridea Wealth Management LLC’s holdings in HealthEquity were worth $2,446,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of HQY. Sivia Capital Partners LLC acquired a new position in HealthEquity in the 2nd quarter worth about $306,000. Arrowstreet Capital Limited Partnership acquired a new stake in HealthEquity in the second quarter valued at approximately $4,747,000. Marshall Wace LLP acquired a new stake in HealthEquity in the second quarter valued at approximately $5,483,000. Amundi increased its position in shares of HealthEquity by 9.3% in the second quarter. Amundi now owns 30,203 shares of the company’s stock valued at $3,059,000 after buying an additional 2,574 shares in the last quarter. Finally, Jump Financial LLC purchased a new stake in shares of HealthEquity in the second quarter valued at approximately $449,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Insider Buying and Selling at HealthEquity

In other news, EVP Michael Henry Fiore sold 3,142 shares of the company’s stock in a transaction on Friday, May 29th. The shares were sold at an average price of $95.00, for a total transaction of $298,490.00. Following the completion of the sale, the executive vice president owned 59,113 shares of the company’s stock, valued at $5,615,735. This represents a 5.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $219,510.00. Following the completion of the sale, the director owned 19,733 shares of the company’s stock, valued at $1,775,970. This trade represents a 11.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 13,081 shares of company stock worth $1,193,000. Corporate insiders own 1.60% of the company’s stock.

Analyst Upgrades and Downgrades

HQY has been the topic of a number of recent analyst reports. Citigroup reiterated a “market outperform” rating on shares of HealthEquity in a research report on Monday, June 1st. BMO Capital Markets raised shares of HealthEquity from a “market perform” rating to an “outperform” rating and boosted their price target for the stock from $85.00 to $105.00 in a report on Thursday, April 9th. Wells Fargo & Company set a $111.00 price target on shares of HealthEquity in a report on Monday, June 1st. Citizens Jmp upped their price objective on shares of HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a research report on Monday, June 1st. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of HealthEquity from $120.00 to $128.00 and gave the company a “buy” rating in a report on Thursday, March 19th. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $110.57.

HealthEquity Price Performance

Shares of HealthEquity stock opened at $88.46 on Friday. The business has a 50 day simple moving average of $85.30 and a two-hundred day simple moving average of $84.77. HealthEquity, Inc. has a 12 month low of $72.76 and a 12 month high of $106.60. The stock has a market capitalization of $7.40 billion, a P/E ratio of 33.13, a PEG ratio of 1.40 and a beta of 0.21. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44.

HealthEquity (NASDAQ:HQY) last released its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.13. The business had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The company’s revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, analysts predict that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.